| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
26,131 |
13,931 |
$31K |
| 80053 |
Comprehensive metabolic panel |
21,406 |
12,050 |
$31K |
| 83880 |
|
3,193 |
1,781 |
$16K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
973 |
912 |
$13K |
| 83735 |
|
11,467 |
3,238 |
$13K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
673 |
601 |
$12K |
| 84145 |
|
3,141 |
1,754 |
$11K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
8,947 |
3,371 |
$11K |
| 84484 |
|
6,376 |
4,854 |
$11K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,345 |
1,260 |
$10K |
| 87040 |
|
2,904 |
2,231 |
$8K |
| 82330 |
|
3,850 |
1,811 |
$8K |
| 83605 |
|
3,582 |
2,198 |
$6K |
| 83690 |
|
5,066 |
4,432 |
$6K |
| 85027 |
|
4,860 |
2,168 |
$5K |
| 85730 |
|
3,991 |
2,531 |
$5K |
| 81001 |
|
8,773 |
8,055 |
$4K |
| 85610 |
|
6,142 |
3,979 |
$4K |
| 84100 |
|
5,739 |
1,230 |
$4K |
| 85379 |
|
2,535 |
1,067 |
$4K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,429 |
1,305 |
$4K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
1,615 |
1,570 |
$3K |
| 82803 |
|
1,017 |
443 |
$3K |
| 80306 |
|
2,422 |
2,209 |
$2K |
| 82077 |
|
1,723 |
1,579 |
$2K |
| 80047 |
|
1,773 |
1,721 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,779 |
1,645 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
122 |
119 |
$2K |
| 87186 |
|
1,024 |
875 |
$1K |
| 87077 |
|
947 |
791 |
$1K |
| 86140 |
|
1,850 |
602 |
$1K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
297 |
285 |
$1K |
| 86900 |
|
2,306 |
1,864 |
$1K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
879 |
827 |
$1K |
| 86901 |
|
2,351 |
1,865 |
$1K |
| 86850 |
|
1,896 |
1,622 |
$995.68 |
| 80202 |
|
444 |
198 |
$884.56 |
| 87070 |
|
605 |
461 |
$869.82 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
633 |
558 |
$848.68 |
| 80179 |
|
600 |
571 |
$683.36 |
| 80143 |
|
636 |
602 |
$665.74 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
191 |
189 |
$638.02 |
| 82728 |
|
135 |
86 |
$536.00 |
| 84702 |
|
230 |
215 |
$530.34 |
| 87081 |
|
488 |
457 |
$524.60 |
| 80076 |
|
424 |
243 |
$516.39 |
| 82550 |
|
548 |
273 |
$513.88 |
| 83550 |
|
459 |
420 |
$489.90 |
| 87205 |
|
590 |
433 |
$472.66 |
| 83540 |
|
529 |
468 |
$456.05 |
| 83615 |
|
540 |
76 |
$372.38 |
| 87641 |
|
72 |
70 |
$343.48 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
80 |
79 |
$308.45 |
| 85384 |
|
129 |
79 |
$302.75 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
71 |
69 |
$247.66 |
| 87631 |
|
41 |
40 |
$236.52 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
71 |
69 |
$234.90 |
| 84439 |
|
162 |
155 |
$221.70 |
| 80061 |
Lipid panel |
112 |
107 |
$204.64 |
| 85652 |
|
413 |
308 |
$156.06 |
| 87400 |
|
145 |
144 |
$85.40 |
| 87430 |
|
28 |
27 |
$45.87 |
| 82140 |
|
15 |
12 |
$43.21 |
| 86592 |
|
78 |
78 |
$37.18 |
| 84703 |
|
28 |
28 |
$16.66 |
| 85380 |
|
28 |
26 |
$15.35 |
| 80365 |
|
15 |
15 |
$9.00 |
| 86880 |
|
13 |
12 |
$8.55 |
| 0353U |
|
24 |
24 |
$0.00 |
| 80329 |
|
30 |
29 |
$0.00 |